Fig. 5.
Galectin-3 SiRNA-mediated inhibition of HSC activation in vivo. (a) Galectin-3 and α-SMA staining of liver tissue harvested 3 days after CCL4 injury (n = 6 mice in each group). Mice received saline (PBS), control duplex (CD), or Galectin-3 siRNA (siRNA). (Scale bar: 200 μm.) (b Left) Real-time PCR quantitation of Galectin-3 expression in liver homogenates 3 days after CCL4 injury. ∗∗, P < 0.01 compared with CD. (b Right) Real-time PCR analysis of α-SMA expression in liver homogenates 3 days after CCL4 injury. ∗∗, P < 0.01 compared with CD.